Table 2 Correlations between consumption levels of prescription opioids, non-medical prescription opioid use, prescription opioid-related morbidity and prescription opioid-related mortality measures in the United States from 2001 – 2010
NMPOU prevalence (past month) | NMPOU prevalence (past year) | NMPOU prevalence (lifetime) | Average number of days per year per person of NMPOU (general population) | Average number of days per year per person of NMPOU (NMPOU users) | Substance abuse treatment admissions for POs per 10,000 people | PO overdose deaths per 100,000 people | |
|---|---|---|---|---|---|---|---|
R-value | 0.741 | 0.638 | 0.753 | 0.900 | 0.720 | 0.951 | 0.988 |
95% CI | 0.208-0.935 | 0.014-0.904 | 0.235-0.938 | 0.625-0.976 | 0.165-0.929 | 0.780-0.990 | 0.949-0.997 |